Daly James M — SEC insider filings

SEC reporting owner CIK 1560782. 36 insider filings on record with FilingPulse; latest filed 2026-10-20.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-08-13 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MADRIGAL PHARMACEUTICALS, INC. (MDGL)Director8—19 legs · 47,959 sh · $13,593,75619
HALOZYME THERAPEUTICS, INC. (HALO)Director8—4 legs · 64,700 sh · $2,293,2136
ACADIA PHARMACEUTICALS INC (ACAD)Director7—1 leg · 30,000 sh · $670,98324
BELLICUM PHARMACEUTICALS, INC (BLCM)Director7——10
CYTOKINETICS INC (CYTK)Director6——7

Insider filings — Daly James M

FiledFormIssuerReported transactionsSource
2026-10-204CYTOKINETICS INC (CYTK)Grant/award (A): 195 @ $63.92EDGAR
2026-10-023HALOZYME THERAPEUTICS, INC. (HALO)Holdings only — no transactions reportedEDGAR
2026-10-024HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 1,169 @ $0 · Grant/award (A): 1,775 (derivative) @ $0EDGAR
2026-07-164CYTOKINETICS INC (CYTK)Grant/award (A): 151 @ $82.62EDGAR
2026-06-184MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 454 @ $0 · Grant/award (A): 766 (derivative) @ $0EDGAR
2026-06-014ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 8,107 · Option exercise (M): 8,107 (derivative) @ $0 · Grant/award (A): 16,004 (derivative) @ $0 · Grant/award (A): 9,311 (derivative) @ $0EDGAR
2026-05-274CYTOKINETICS INC (CYTK)Grant/award (A): 2,851 @ $0 · Grant/award (A): 4,301 (derivative) @ $0EDGAR
2026-04-154CYTOKINETICS INC (CYTK)Grant/award (A): 191 @ $65.37EDGAR
2026-01-204CYTOKINETICS INC (CYTK)Grant/award (A): 197 @ $63.44EDGAR
2025-11-124ACADIA PHARMACEUTICALS INC (ACAD)Sale (S): 30,000 @ $22.37EDGAR
2025-08-204CYTOKINETICS INC (CYTK)Grant/award (A): 27,450 (derivative) @ $0EDGAR
2025-06-244MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 715 @ $0 · Grant/award (A): 1,290 (derivative) @ $0EDGAR
2025-06-024ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 9,387 · Option exercise (M): 9,387 (derivative) @ $0 · Grant/award (A): 13,793 (derivative) @ $0 · Grant/award (A): 8,107 (derivative) @ $0EDGAR
2025-02-284MADRIGAL PHARMACEUTICALS, INC. (MDGL)Option exercise (M): 9,470 @ $65.06 · Option exercise (M): 6,000 @ $111.06 · Sale (S): 398 @ $346.90 · Sale (S): 14,302 @ $347.39 · Sale (S): 770 @ $348.94 · Option exercise (M): 9,470 (derivative) @ $0 · +1 moreEDGAR
2024-06-274MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 714 @ $0 · Grant/award (A): 1,105 (derivative) @ $0EDGAR
2024-05-314ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 6,652 · Option exercise (M): 6,652 (derivative) @ $0 · Grant/award (A): 15,959 (derivative) @ $0 · Grant/award (A): 9,387 (derivative) @ $0EDGAR
2024-04-034MADRIGAL PHARMACEUTICALS, INC. (MDGL)Option exercise (M): 20,000 @ $100.45 · Option exercise (M): 1,577 @ $105.08 · Sale (S): 6,809 @ $255.64 · Sale (S): 7,401 @ $256.50 · Sale (S): 3,604 @ $257.30 · Sale (S): 1,460 @ $258.28 · +16 moreEDGAR
2023-08-154HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 10,000 @ $43.71 · Sale (S): 10,000 @ $43.74EDGAR
2023-06-204MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 1,198 @ $0EDGAR
2023-06-054ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 3,059 · Option exercise (M): 6,391 · Option exercise (M): 8,552 · Option exercise (M): 3,059 (derivative) @ $0 · Option exercise (M): 6,391 (derivative) @ $0 · Option exercise (M): 8,552 (derivative) @ $0 · +2 moreEDGAR
2023-05-094HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 8,065 @ $0 · Grant/award (A): 11,371 (derivative) @ $0EDGAR
2023-01-054BELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 60,414 @ $0EDGAR
2022-09-024BELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 35,082 @ $0EDGAR
2022-06-214MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 9,470 (derivative) @ $0EDGAR
2022-06-164BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-094ACADIA PHARMACEUTICALS INC (ACAD)Grant/award (A): 14,368 (derivative) @ $0 · Grant/award (A): 8,552 (derivative) @ $0EDGAR
2022-05-064HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 6,206 @ $0EDGAR
2022-01-064BELLICUM PHARMACEUTICALS, INC (BLCM)Option exercise (M): 13,568 @ $0 · Option exercise (M): 809 @ $0 · Option exercise (M): 13,568 (derivative) @ $0 · Option exercise (M): 809 (derivative) @ $0EDGAR
2021-07-074BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 6,500 (derivative) @ $0EDGAR
2021-07-064BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 809 (derivative) @ $0EDGAR
2021-06-244ACADIA PHARMACEUTICALS INC (ACAD)Grant/award (A): 11,637 (derivative) @ $0 · Grant/award (A): 6,391 (derivative) @ $0EDGAR
2021-06-214MADRIGAL PHARMACEUTICALS, INC. (MDGL)Grant/award (A): 12,489 (derivative) @ $0EDGAR
2021-05-064HALOZYME THERAPEUTICS, INC. (HALO)Grant/award (A): 5,230 @ $0EDGAR
2021-01-054BELLICUM PHARMACEUTICALS, INC (BLCM)Grant/award (A): 13,568 (derivative) @ $0EDGAR
2020-11-254HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 10,363 @ $40.41EDGAR
2020-08-134HALOZYME THERAPEUTICS, INC. (HALO)Sale (S): 34,337 @ $29.12EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1560782 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs